BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35634767)

  • 1. Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.
    Chu BK; Tsai RF; Hung CL; Kuo YH; Chen EH; Chiang YW; Chan SI; Chen RP
    Protein Sci; 2022 Jun; 31(6):e4326. PubMed ID: 35634767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segments in the Amyloid Core that Distinguish Hamster from Mouse Prion Fibrils.
    Shen HC; Chen YH; Lin YS; Chu BK; Liang CS; Yang CC; Chen RP
    Neurochem Res; 2019 Jun; 44(6):1399-1409. PubMed ID: 30603982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Seeding Assay in the Investigation of the Amyloid Core of Prion Fibrils.
    Chu BK; Lin YS; Shen HC; Chen RP
    Methods Mol Biol; 2023; 2551():633-647. PubMed ID: 36310229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein.
    Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y
    J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of spin exchange interactions to identify β strand and turn regions in Ure2 prion domain fibrils with site-directed spin labeling.
    Ngo S; Chiang V; Guo Z
    J Struct Biol; 2012 Nov; 180(2):374-81. PubMed ID: 22967940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
    Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
    Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical organization in the amyloid core of yeast prion protein Ure2.
    Ngo S; Gu L; Guo Z
    J Biol Chem; 2011 Aug; 286(34):29691-9. PubMed ID: 21730048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
    Groveman BR; Dolan MA; Taubner LM; Kraus A; Wickner RB; Caughey B
    J Biol Chem; 2014 Aug; 289(35):24129-42. PubMed ID: 25028516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural biology of ex vivo mammalian prions.
    Artikis E; Kraus A; Caughey B
    J Biol Chem; 2022 Aug; 298(8):102181. PubMed ID: 35752366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR.
    Lundberg KM; Stenland CJ; Cohen FE; Prusiner SB; Millhauser GL
    Chem Biol; 1997 May; 4(5):345-55. PubMed ID: 9195875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
    Tycko R; Wickner RB
    Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mechanism for transmissible prion diseases.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
    J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
    Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23-144) Fibrils.
    Lee CH; Saw JE; Chen EH; Wang CH; Uchihashi T; Chen RP
    J Mol Biol; 2024 Jun; 436(11):168576. PubMed ID: 38641239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.